Why the study?
Does intracavernous administration of Angiopoietin-4 improve erectile function in streptozotocin-induced diabetic mice?
Does intracavernous administration of Angiopoietin-4 improve erectile function in streptozotocin-induced diabetic mice?
Angiopoietin-4 may promote cavernous endothelial regeneration and improve erectile function in diabetic models.
Hypothesis-generating for Ang-4 in diabetic ED; clinical trials needed before any practice consideration.
Cavernous endothelial regeneration by use of Ang-4 protein may have potential for the treatment of vascular disease-induced ED, such as diabetic ED.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: